Latest Insider Transactions at Geo Vax Labs, Inc. (GOVX)
This section provides a real-time view of insider transactions for Geo Vax Labs, Inc. (GOVX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GeoVax Labs, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GeoVax Labs, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 09
2024
|
David A Dodd President, CEO |
BUY
Open market or private purchase
|
Direct |
8,000
+23.08%
|
$8,000
$1.95 P/Share
|
|
Feb 22
2024
|
David A Dodd President, CEO |
BUY
Open market or private purchase
|
Direct |
8,209
+30.55%
|
$16,418
$2.27 P/Share
|
|
Feb 21
2024
|
David A Dodd President, CEO |
BUY
Open market or private purchase
|
Direct |
520
+4.74%
|
$1,040
$2.15 P/Share
|
|
Feb 07
2024
|
Mark Reynolds CFO |
BUY
Open market or private purchase
|
Direct |
2,000
+21.71%
|
$4,000
$2.77 P/Share
|
|
Dec 22
2023
|
Kelly T. Mc Kee Jr. Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
6,944
+16.25%
|
$0
$0.36 P/Share
|
|
Sep 25
2023
|
Kelly T. Mc Kee Jr. Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
9,653
+25.08%
|
$0
$0.52 P/Share
|
|
Aug 25
2023
|
David A Dodd President, CEO |
BUY
Open market or private purchase
|
Direct |
35,087
+19.06%
|
$0
$0.57 P/Share
|
|
Aug 18
2023
|
Mark Reynolds CFO |
BUY
Open market or private purchase
|
Direct |
10,000
+11.34%
|
$0
$0.52 P/Share
|
|
Apr 24
2023
|
David A Dodd President, CEO |
BUY
Open market or private purchase
|
Direct |
32,000
+21.94%
|
$0
$0.64 P/Share
|
|
Apr 20
2023
|
Mark Reynolds CFO |
BUY
Open market or private purchase
|
Direct |
8,000
+10.5%
|
$0
$0.63 P/Share
|
|
Sep 21
2022
|
Randal D Chase Director |
BUY
Open market or private purchase
|
Direct |
10,000
+21.45%
|
$10,000
$1.1 P/Share
|
|
Jul 01
2022
|
John W. Sharkey VP, Business Development |
BUY
Open market or private purchase
|
Direct |
1,000
+25.91%
|
$0
$0.82 P/Share
|
|
Jun 27
2022
|
Kelly T. Mc Kee Jr. Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
4,464
+18.88%
|
$4,464
$1.12 P/Share
|
|
Jun 21
2022
|
Randal D Chase Director |
BUY
Open market or private purchase
|
Direct |
10,000
+27.31%
|
$10,000
$1.21 P/Share
|
|
May 05
2022
|
Kelly T. Mc Kee Jr. Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
9,722
+39.77%
|
$0
$0.72 P/Share
|
|
May 04
2022
|
Kelly T. Mc Kee Jr. Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
4,999
+50.0%
|
$0
$0.71 P/Share
|